7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...

7/26/2025China's Sciwind in Licensing Talks to Bring Weight-Loss Drug to U.S. M...

7/26/2025Recent Official and Executive Moves

7/26/2025China's Basic Medical Insurance Fund Reports Surplus in H1/2025

7/26/2025Ambroxol Hydrochloride Drops Reclassified as OTC Drug in China

7/25/2025Newish Secures Series B1 Investment to Propel Nucleic Acid Cancer Vac...

7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod

7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China

7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...

7/25/2025Everest Secures $200M in Share Placement while Epirium Bio Prepares $5...

7/25/2025China Launches Nationwide Pilot Program for Smart Medical Insurance Ov...

7/24/2025Roche Sees Strong China Pharma Growth in H12025

7/24/2025Pfizer Finalizes 3SBio Deal, Prepares Global Phase 3 Launch for BsAb S...

7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107

7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC

7/24/2025Zonsen PepLib Biotech Closes ~CNY 100M Series B Round

7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals

7/23/2025SAMR Orders Simcere to Reverse Unnotified Merger Over Competition, Pri...

7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...

7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...

7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...

7/22/2025CDE Solicits Comments on Proposed Labeling Update for Pediatric Use of...

7/22/2025CDE Issues Q&A Guidance on Pharmaceutical Similarity Studies for Biosi...

7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...

7/22/2025Cloudbreak Pharma Reports Positive Phase 2 Outcomes for CBT‑004

7/22/2025Novatim Licenses Global Rights for Dual-Target CAR-T Therapy KQ-2003 t...

7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...

7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...

7/22/2025Leads Biolabs' Hong Kong IPO Draws HK$220B in Overwhelming Demand

7/22/2025Suzhou Ribo Raises Over CNY 200M to Advance siRNA Therapeutics

Page:1/54 Total number of articles:1609: [First][<<] [1] [2] [3] [4] [5] [>>] [End]